Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,162 public trials 6,471 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 17 locations
View Trial Details
Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

NCT06116110

Conditions
Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations
  • Stanford University Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

NCT05708352

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Pacific Neuroscience Institute / Saint John's Cancer Institute Santa Monica, California, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Recruiting

Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma

NCT07699939

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +4 more
Locations
  • Chiba Cancer Center Chiba, Japan
  • Kyushu Cancer Center Fukuoka, Japan
  • Gifu University Hospital Gifu, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
View all 18 locations
View Trial Details
Recruiting

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

NCT06445114

Conditions
Carcinoma, Head and Neck Neoplasms, Neoplasms, +10 more
Locations
  • Cedars-Sinai Cancer at Beverly Hills (THO) Beverly Hills, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • CS Cancer at Valley Oncology Medical Group Tarzana, California, United States
  • CS Cancer at the Hunt Cancer Center Torrance, California, United States
View Trial Details

Related conditions